Motilal Oswal Financial Services has upgraded Oil and Natural Gas Corporation (ONGC) to a BUY rating, setting a target price of Rs 288 against a current market price of Rs 235 — im
News in Focus
Motilal Oswal Financial Services (MOFSL) has reiterated a BUY rating on Eternal (formerly Zomato), setting a target price of Rs 380 against a current market price
Deven Choksey Research has issued an ACCUMULATE rating on Cipla Ltd, setting a target price of Rs 1,589 against a current market price of Rs 1,432 — an implied upside of 11%.
Deven Choksey Research has reiterated a BUY call on Kotak Mahindra Bank Ltd., setting a target price of Rs 434 against the current market price of Rs 370, implying an upside of about 17%.
ICICI Securities has reaffirmed a BUY rating on WeWork India Management, holding its target price steady at Rs 937 — implying roughly 36% upside from the current market price of Rs 689.
Anupama Written Episode Update for July 6, 2026: Diary Drama Escalates. Well, darling, buckle up — today's episode of Anupama serves more twists than a Bollywood plot at intermission.
Main Regional Stories
Featured, India Business, Stock Markets, Geojit BNP Paribas, Hindalco Industries, India, Metals Sector
Geojit Investments Limited has issued a Buy recommendation on Hindalco Industries Limited, the metals flagship of the Aditya Birla Group, setting a 12-month target price of Rs 1,074 against a curr
Geojit Investments Limited has rolled back its bullish stance on Tata Steel Limited, downgrading the counter from BUY to HOLD in a report dated July 2, 2026, even as the steelmaker posted a blowout fourth quarter.
Featured, India Business, Analyst View, Finance Sector, Geojit Financial Services, India, JIO Financial Services
Geojit Investments Limited, a SEBI-registered research entity, has reaffirmed a BUY rating on Jio Financial Services Limited (JFSL), even as the NBFC's fourth-quarter profit contracted year-on-year.
Featured, India Business, Analyst View, Geojit Financial Services, India, Pharmaceutical Sector, Strides Pharma
Geojit Investments Limited has maintained a BUY rating on Strides Pharma Science Ltd. (NSE: STAR), setting a revised 12-month target price of Rs 1,352 against a current market price of Rs 1,122 — implying a potential upside of roughly 20 percent.
